CHICAGO -- Gene therapy for Danon disease, a rare inherited cause of hypertrophic cardiomyopathy, appeared to improve or ...
Nov 13 (Reuters) - The U.S. Food and Drug Administration approved PTC Therapeutics' (PTCT.O), opens new tab gene therapy to ...
On Monday, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) presented long-term safety and efficacy results from the Phase 1 study ...
Talks with the FDA haven’t gone according to plan. Seeking a streamlined pathway, Neurogene submitted a Regenerative Medicine ...
The treatment is the first approved gene therapy for AADC deficiency, the FDA said. People with this rare disorder have ...
Failing to receive the RMAT designation from the FDA for its early-stage Batten disease gene therapy, Neurogene tells ...
A new type of therapy that "edits" a gene in patients with a rare heart condition has been shown to be safe and effective, ...
In another sign of biopharma's waning interest in the traditional ex vivo gene therapy approach, CSL Behring is shutti | CSL ...
Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the peer-reviewed ...
Harvard Medical School researchers have taken another decisive step in their efforts to develop a gene therapy for people ...
In a significant move towards the liberalization of the healthcare sector, Shanghai's Pudong New Area witnessed the first ...
The FDA has granted fast-track approval for a groundbreaking gene therapy indicated for a rare genetic disorder called ...